-19.0%
CPRT vs MRNA
-24.9%
+5.9%
-58.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | +1.3% | -3.2% | -2.0% |
| 7D | -3.6% | -13.8% | +10.3% | -2.8% |
| 30D | +10.9% | -17.7% | +28.5% | +11.8% |
| 3M | -8.8% | +14.3% | -23.1% | -10.3% |
| 6M | -6.8% | +336.0% | -342.8% | -20.2% |
| YTD | -21.2% | +575.9% | -597.1% | -35.9% |
| 1Y | -25.4% | +724.4% | -749.8% | -40.7% |
| 3Y | -38.6% | +160.8% | -199.3% | -47.7% |
| 5Y | -19.0% | -24.4% | +5.4% | -27.0% |
| All | -19.0% | -24.9% | +5.9% | -27.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling